Klauss Villalva-Serra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Klauss Villalva-Serra has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Bezerril Andrade
Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland
12 shared publications Marcelo Cordeiro-Santos
Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil
5 shared publicationsMariana Araújo-Pereira
Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil
5 shared publicationsAfrânio L. Kritski
4 shared publicationsArtur T.L. Queiroz
4 shared publicationsBeatriz Barreto-Duarte
Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Bahia, Brazil
4 shared publications
Latest Publications
- Open Access
- 9 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Institutional predictors of minimum proficiency in Brazil’s new National Medical Education Assessment (ENAMED): a Bayesian hierarchical nationwide cross-sectional analysis (Preprint)
BACKGROUND Brazil’s medical education system has expanded at unprecedented pacing, largely propelled by policies meant to increase the physician workforce and reduce regional inequities. This expansion succeeded in scale, but it reignited an old question: are we expanding training capacity or expanding diplomas? In 2025, Brazil introduced the National Medical Education Assessment Examination (ENAMED), a regulatory instrument grounded in a simple principle: programs should be judged, and effectively ranked, by the proportion of graduating students who meet a defined minimum standard of professional proficiency (knowledge-based), rather than by mean scores alone. OBJECTIVE We evaluated institutional and structural determinants of ENAMED performance, focusing on the system’s ability to guarantee minimum proficiency across medical schools amid recent expansion patterns. METHODS We conducted a nationwide retrospective observational analysis linking ENAMED-2025 results to institutional and regulatory characteristics of medical programs. Our outcome was systemic assurance of minimum proficiency, defined as meeting a regulatory benchmark in which ≥60% of graduates are classified as proficient. We fit hierarchical Bayesian models estimating each program’s posterior probability of meeting this benchmark, accounting for course size and geographic clustering (state and municipality). RESULTS ENAMED revealed pronounced heterogeneity in the probability of meeting the minimum proficiency benchmark across institutional segments. Federal and state public medical schools had the highest assurance, followed by community-based institutions. Private programs, especially for-profit schools, showed substantially lower probabilities of meeting the benchmark. Programs created during the most recent waves of expansion and those with larger volumes of authorized enrollments consistently exhibited weaker assurance. Independently, greater enrollment capacity was associated with lower probability of achieving the ≥60% proficiency threshold, with the steepest gradient observed among for-profit institutions. CONCLUSIONS ENAMED’s signal is strongly shaped by institutional design and conditions under which expansion occurred, far more than by chance variation. By privileging the share of graduates who reach a minimum proficiency standard, ENAMED shifts regulation from “average performance” to “minimum guarantees,” offering a more defensible lens for accountability in medical education. Its promise, however, depends on policy responses that strengthen academic governance, clinical training capacity, and faculty support, rather than short-term, reactive strategies aimed at gaming exam performance. CLINICALTRIAL Not applicable.
- 9 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessInstitutional predictors of minimum proficiency in Brazil’s new National Medical Education Assessment (ENAMED): a Bayesian hierarchical nationwide cross-sectional analysis (Preprint)
BACKGROUND Brazil’s medical education system has expanded at unprecedented pacing, largely propelled by policies meant to increase the physician workforce and reduce regional inequities. This expansion succeeded in scale, but it reignited an old question: are we expanding training capacity or expanding diplomas? In 2025, Brazil introduced the National Medical Education Assessment Examination (ENAMED), a regulatory instrument grounded in a simple principle: programs should be judged, and effectively ranked, by the proportion of graduating students who meet a defined minimum standard of professional proficiency (knowledge-based), rather than by mean scores alone. OBJECTIVE We evaluated institutional and structural determinants of ENAMED performance, focusing on the system’s ability to guarantee minimum proficiency across medical schools amid recent expansion patterns. METHODS We conducted a nationwide retrospective observational analysis linking ENAMED-2025 results to institutional and regulatory characteristics of medical programs. Our outcome was systemic assurance of minimum proficiency, defined as meeting a regulatory benchmark in which ≥60% of graduates are classified as proficient. We fit hierarchical Bayesian models estimating each program’s posterior probability of meeting this benchmark, accounting for course size and geographic clustering (state and municipality). RESULTS ENAMED revealed pronounced heterogeneity in the probability of meeting the minimum proficiency benchmark across institutional segments. Federal and state public medical schools had the highest assurance, followed by community-based institutions. Private programs, especially for-profit schools, showed substantially lower probabilities of meeting the benchmark. Programs created during the most recent waves of expansion and those with larger volumes of authorized enrollments consistently exhibited weaker assurance. Independently, greater enrollment capacity was associated with lower probability of achieving the ≥60% proficiency threshold, with the steepest gradient observed among for-profit institutions. CONCLUSIONS ENAMED’s signal is strongly shaped by institutional design and conditions under which expansion occurred, far more than by chance variation. By privileging the share of graduates who reach a minimum proficiency standard, ENAMED shifts regulation from “average performance” to “minimum guarantees,” offering a more defensible lens for accountability in medical education. Its promise, however, depends on policy responses that strengthen academic governance, clinical training capacity, and faculty support, rather than short-term, reactive strategies aimed at gaming exam performance. CLINICALTRIAL Not applicable.
- Open Access
- 22 April 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (4) , e021546
Programmatic impact and cost-effectiveness of scaling up the short-course 3HP regimen for tuberculosis preventive treatment in Brazil
Background: Tuberculosis preventive therapy (TPT) is critical in interrupting progression to disease, transmission and reducing incidence rates. Nonetheless, high costs have been barriers towards the expansion of shorter patient-friendly drug regimens. In 2019, a Unitaid-led deal reduced rifapentine costs by over 70%, facilitating Brazil’s implementation of 3 months of rifapentine+isoniazid (3HP), a short-course TPT regimen, in its public health system. We evaluated the health and economic impact of Brazil’s implementation of this patient-friendly regimen for short-course TPT. Methods: We analysed surveillance data on 171 174 individuals initiating TPT from January 2019 to December 2024. A mixed-effects spatiotemporal Bayesian model estimated quarterly TPT initiation trends under (1) observed 3HP rollout versus a no-3HP counterfactual (Q3 2021–Q4 2024) and (2) projected universal 3HP coverage (Q1 2025–Q4 2027) versus extended no-3HP adoption. Cost-effectiveness analysis quantified active tuberculosis (TB) cases and disability-adjusted life-years (DALYs) averted, alongside costs, incremental cost-effectiveness ratios, net monetary benefits (NMBs) and return on investment of TPT under each 3HP coverage scenario. Results: From 2022 to 2024, 3HP scale-up produced 37 508.4 (95% credible intervals (CrIs) 31 405.2 to 43 631.6) additional TPT initiations, averted an estimated 15 002 DALYs (95% CrI 8985.6 to 21 031.15) and yielded NMBs of US$122.7 million (95% CrI US$63.8 to US$198.2 million). Under a proposed universal coverage (2025–2027), projected gains included 72 080.1 (95% CrI 62 323.7 to 81 836.4) additional individuals starting TPT, with subsequent 26 139 DALYs averted (95% CrI 14 117 to 38 762) and NMBs of US$214.5 million (95% CrI US$103.0 to US$362.8 million), indicating strong economic dominance over no-3HP adoption. Finally, TPT with 3HP’s implementation was estimated to return US$1.31 (95% CrI US$0.97 to US$1.62) to the health system for every US$1 invested. Conclusions: In Brazil, large-scale implementation of a patient-friendly short-course regimen (3HP) was effective and likely cost-saving for a resource-strained public health system. Our evaluation provides robust, real-world evidence that implementing this regimen improved TPT coverage and completion nationwide while reducing costs and TB disease burden.
- 22 April 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (4) , e021546
Open AccessProgrammatic impact and cost-effectiveness of scaling up the short-course 3HP regimen for tuberculosis preventive treatment in Brazil
Background: Tuberculosis preventive therapy (TPT) is critical in interrupting progression to disease, transmission and reducing incidence rates. Nonetheless, high costs have been barriers towards the expansion of shorter patient-friendly drug regimens. In 2019, a Unitaid-led deal reduced rifapentine costs by over 70%, facilitating Brazil’s implementation of 3 months of rifapentine+isoniazid (3HP), a short-course TPT regimen, in its public health system. We evaluated the health and economic impact of Brazil’s implementation of this patient-friendly regimen for short-course TPT. Methods: We analysed surveillance data on 171 174 individuals initiating TPT from January 2019 to December 2024. A mixed-effects spatiotemporal Bayesian model estimated quarterly TPT initiation trends under (1) observed 3HP rollout versus a no-3HP counterfactual (Q3 2021–Q4 2024) and (2) projected universal 3HP coverage (Q1 2025–Q4 2027) versus extended no-3HP adoption. Cost-effectiveness analysis quantified active tuberculosis (TB) cases and disability-adjusted life-years (DALYs) averted, alongside costs, incremental cost-effectiveness ratios, net monetary benefits (NMBs) and return on investment of TPT under each 3HP coverage scenario. Results: From 2022 to 2024, 3HP scale-up produced 37 508.4 (95% credible intervals (CrIs) 31 405.2 to 43 631.6) additional TPT initiations, averted an estimated 15 002 DALYs (95% CrI 8985.6 to 21 031.15) and yielded NMBs of US$122.7 million (95% CrI US$63.8 to US$198.2 million). Under a proposed universal coverage (2025–2027), projected gains included 72 080.1 (95% CrI 62 323.7 to 81 836.4) additional individuals starting TPT, with subsequent 26 139 DALYs averted (95% CrI 14 117 to 38 762) and NMBs of US$214.5 million (95% CrI US$103.0 to US$362.8 million), indicating strong economic dominance over no-3HP adoption. Finally, TPT with 3HP’s implementation was estimated to return US$1.31 (95% CrI US$0.97 to US$1.62) to the health system for every US$1 invested. Conclusions: In Brazil, large-scale implementation of a patient-friendly short-course regimen (3HP) was effective and likely cost-saving for a resource-strained public health system. Our evaluation provides robust, real-world evidence that implementing this regimen improved TPT coverage and completion nationwide while reducing costs and TB disease burden.
- Open Access
- 3 March 2026
- Published by JMIR Publications Inc. in JMIR Infodemiology
- Vol. 6, e78843
Audience-Specific Health Communication: Mixed Methods Evaluation of the Maria Ciência AI-Assisted Knowledge Translation Tool
Background: Scientific misinformation remains a major barrier to effective health communication. Bridging the gap between academic research and public understanding requires tools that simplify scientific language and adapt content to diverse audiences. Objective: This study presents Maria Ciência (LPCT-IGM), a specialized GPT-based assistant for science communication. The tool supports researchers in translating peer-reviewed scientific findings through simple prompts into accessible, ethically appropriate materials tailored for children, the general public, health professionals, and policymakers. Methods: The tool was configured using prompt engineering techniques and guided by curated reference materials on inclusive and nonstigmatizing scientific language. Materials derived from 47 public health papers resulted in 188 outputs, which were assessed by 121 evaluators using 4 criteria: clarity, level of detail, language suitability, and content quality. In addition, outputs generated by Maria Ciência were compared with those produced by a base large language model and with human-written science communication materials. Readability and linguistic accessibility were assessed using multiple established metrics. Results: Worldwide, mean scores were high: clarity (4.90), language suitability (4.78), content quality (4.72), and level of detail (4.56), on a 5-point scale. Materials for children and the general public consistently achieved the highest ratings across all criteria. A targeted comparison with the base large language model demonstrated superior performance of Maria Ciência in contextual stability. Readability analyses indicated that Maria Ciência’s outputs were significantly more accessible than human-written texts, while maintaining high legibility classifications. Conclusions: Maria Ciência demonstrates the potential of artificial intelligence–assisted tools to enhance knowledge translation and counter scientific misinformation by producing scalable, audience-specific content that balances accessibility and informational integrity.
- 3 March 2026
- Published by JMIR Publications Inc. in JMIR Infodemiology
- Vol. 6, e78843
Open AccessAudience-Specific Health Communication: Mixed Methods Evaluation of the Maria Ciência AI-Assisted Knowledge Translation Tool
Background: Scientific misinformation remains a major barrier to effective health communication. Bridging the gap between academic research and public understanding requires tools that simplify scientific language and adapt content to diverse audiences. Objective: This study presents Maria Ciência (LPCT-IGM), a specialized GPT-based assistant for science communication. The tool supports researchers in translating peer-reviewed scientific findings through simple prompts into accessible, ethically appropriate materials tailored for children, the general public, health professionals, and policymakers. Methods: The tool was configured using prompt engineering techniques and guided by curated reference materials on inclusive and nonstigmatizing scientific language. Materials derived from 47 public health papers resulted in 188 outputs, which were assessed by 121 evaluators using 4 criteria: clarity, level of detail, language suitability, and content quality. In addition, outputs generated by Maria Ciência were compared with those produced by a base large language model and with human-written science communication materials. Readability and linguistic accessibility were assessed using multiple established metrics. Results: Worldwide, mean scores were high: clarity (4.90), language suitability (4.78), content quality (4.72), and level of detail (4.56), on a 5-point scale. Materials for children and the general public consistently achieved the highest ratings across all criteria. A targeted comparison with the base large language model demonstrated superior performance of Maria Ciência in contextual stability. Readability analyses indicated that Maria Ciência’s outputs were significantly more accessible than human-written texts, while maintaining high legibility classifications. Conclusions: Maria Ciência demonstrates the potential of artificial intelligence–assisted tools to enhance knowledge translation and counter scientific misinformation by producing scalable, audience-specific content that balances accessibility and informational integrity.
- 29 January 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 54
Corrigendum to “Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis” - The Lancet Regional Health – Americas 2025; Volume 41: 100963; DOI: 10.1016/j.lana.2024.100963
- 29 January 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 54
Corrigendum to “Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis” - The Lancet Regional Health – Americas 2025; Volume 41: 100963; DOI: 10.1016/j.lana.2024.100963
- Open Access
- 27 November 2025
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 53, 101305
Interplay between biological & social vulnerability and poor tuberculosis treatment outcome in Brazil: a nationwide study using multivariate modelling with excess risk
- 27 November 2025
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 53, 101305
Open AccessInterplay between biological & social vulnerability and poor tuberculosis treatment outcome in Brazil: a nationwide study using multivariate modelling with excess risk
- Open Access
- 10 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Maria Ciência: Application of Artificial Intelligence for Audience-Specific Health Communication and Knowledge Dissemination (Preprint)
BACKGROUND Scientific misinformation remains a major barrier to effective health communication. Bridging the gap between academic research and public understanding requires tools that simplify scientific language and adapt content to diverse audiences. OBJECTIVE This study presents Maria Ciência, a specialized GPT-based assistant for science communication. The tool supports researchers in translating peer-reviewed scientific findings through simple prompts into accessible, ethically appropriate materials tailored for children, the general public, health professionals, and policymakers. METHODS The tool was configured using prompt engineering techniques and guided by curated reference materials on inclusive and non-stigmatizing scientific language. Materials derived from 47 public health articles resulted in 188 outputs, which were assessed by 121 evaluators using four criteria: clarity, level of detail, language suitability, and content quality. RESULTS Globally, mean scores were high: clarity (4.90), language suitability (4.78), content quality (4.72), and level of detail (4.56), on a 5-point scale. Materials for children and the general public consistently achieved the highest ratings across all criteria. CONCLUSIONS A targeted comparison with the base large language model (ChatGPT 4o) demonstrated superior performance of Maria Ciência in contextual stability. Maria Ciência demonstrates the potential of AI-assisted tools to enhance knowledge translation and counter scientific misinformation by producing scalable, audience-specific content.
- 10 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMaria Ciência: Application of Artificial Intelligence for Audience-Specific Health Communication and Knowledge Dissemination (Preprint)
BACKGROUND Scientific misinformation remains a major barrier to effective health communication. Bridging the gap between academic research and public understanding requires tools that simplify scientific language and adapt content to diverse audiences. OBJECTIVE This study presents Maria Ciência, a specialized GPT-based assistant for science communication. The tool supports researchers in translating peer-reviewed scientific findings through simple prompts into accessible, ethically appropriate materials tailored for children, the general public, health professionals, and policymakers. METHODS The tool was configured using prompt engineering techniques and guided by curated reference materials on inclusive and non-stigmatizing scientific language. Materials derived from 47 public health articles resulted in 188 outputs, which were assessed by 121 evaluators using four criteria: clarity, level of detail, language suitability, and content quality. RESULTS Globally, mean scores were high: clarity (4.90), language suitability (4.78), content quality (4.72), and level of detail (4.56), on a 5-point scale. Materials for children and the general public consistently achieved the highest ratings across all criteria. CONCLUSIONS A targeted comparison with the base large language model (ChatGPT 4o) demonstrated superior performance of Maria Ciência in contextual stability. Maria Ciência demonstrates the potential of AI-assisted tools to enhance knowledge translation and counter scientific misinformation by producing scalable, audience-specific content.
- Open Access
For-Profit Growth and Academic Decline: A Retrospective Nationwide Assessment of Brazilian Medical Schools
Background: The rapid and predominantly for-profit expansion of medical schools in Brazil over the past decade has raised widespread concerns about the erosion of academic standards in medical education. Methods: This nationwide, retrospective study analyzed academic performance indicators from all Brazilian medical schools participating in the 2013, 2016, 2019, and 2023 cycles of the Exame Nacional de Desempenho dos Estudantes (ENADE)—a standardized national exam used to assess students’ knowledge at the end of undergraduate programs. We also included the Indicador de Diferença entre os Desempenhos Observado e Esperado (IDD), which estimates the value added by institutions by comparing student performance at graduation with their academic background at entry. Data were sourced from publicly available datasets provided by the Brazilian Ministry of Education. We compared trends across public, non-profit private, and for-profit private institutions, using descriptive statistics, non-parametric tests, correlation analysis, and Bayesian mixed-effects regression models to assess the impact of institutional category and class size on academic performance. Results: The number of for-profit medical schools in Brazil nearly tripled between 2013 and 2023. These institutions consistently demonstrated lower ENADE scores compared to public and non-profit peers. Although IDD scores showed some early gains, they declined significantly in 2023, particularly among new medical schools taking the ENADE for the first time—most of which were for-profit. Larger class sizes were negatively correlated with both ENADE and IDD scores. Regression models showed that public institutions outperformed for-profit schools by an average margin of more than 21 ENADE points, while class size emerged as a modest but statistically significant negative predictor of IDD. Conclusion: Our findings reveal that the unregulated expansion of for-profit medical schools in Brazil has been accompanied by a decline in academic performance, as measured by national benchmarks. These patterns suggest a structural misalignment between the commercial logic of expansion and the core educational mission of medical training. Regulatory reforms are urgently needed to realign the growth of medical education with principles of academic quality and social accountability.
Open AccessFor-Profit Growth and Academic Decline: A Retrospective Nationwide Assessment of Brazilian Medical Schools
Background: The rapid and predominantly for-profit expansion of medical schools in Brazil over the past decade has raised widespread concerns about the erosion of academic standards in medical education. Methods: This nationwide, retrospective study analyzed academic performance indicators from all Brazilian medical schools participating in the 2013, 2016, 2019, and 2023 cycles of the Exame Nacional de Desempenho dos Estudantes (ENADE)—a standardized national exam used to assess students’ knowledge at the end of undergraduate programs. We also included the Indicador de Diferença entre os Desempenhos Observado e Esperado (IDD), which estimates the value added by institutions by comparing student performance at graduation with their academic background at entry. Data were sourced from publicly available datasets provided by the Brazilian Ministry of Education. We compared trends across public, non-profit private, and for-profit private institutions, using descriptive statistics, non-parametric tests, correlation analysis, and Bayesian mixed-effects regression models to assess the impact of institutional category and class size on academic performance. Results: The number of for-profit medical schools in Brazil nearly tripled between 2013 and 2023. These institutions consistently demonstrated lower ENADE scores compared to public and non-profit peers. Although IDD scores showed some early gains, they declined significantly in 2023, particularly among new medical schools taking the ENADE for the first time—most of which were for-profit. Larger class sizes were negatively correlated with both ENADE and IDD scores. Regression models showed that public institutions outperformed for-profit schools by an average margin of more than 21 ENADE points, while class size emerged as a modest but statistically significant negative predictor of IDD. Conclusion: Our findings reveal that the unregulated expansion of for-profit medical schools in Brazil has been accompanied by a decline in academic performance, as measured by national benchmarks. These patterns suggest a structural misalignment between the commercial logic of expansion and the core educational mission of medical training. Regulatory reforms are urgently needed to realign the growth of medical education with principles of academic quality and social accountability.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e01332025
Tuberculosis and the Research Workforce Renewal Crisis in Brazil: How Can We Prevent a Future Without New Researchers?
Tuberculosis (TB) is among the oldest and deadliest infectious diseases, particularly when associated with human immunodeficiency virus (HIV) and antimicrobial resistance. Despite the progress in prevention, diagnosis, and treatment, global elimination remains elusive and is driven largely by socioeconomic inequalities and systemic challenges. Although scientific research is a cornerstone of the WHO End TB Strategy, it has been chronically underfunded and undervalued in Brazil’s health agenda. One critical consequence is the weakening of pipelines for future TB research. Funding shortages, lack of incentives, and the shifting attention toward s other emerging diseases have made it increasingly difficult to recruit and retain scientists in the field of TB. This opinion paper aimed to explore the historical role of Brazilian science in advancing TB control while addressing the emerging crisis of renewing the country’s TB scientific workforce. We conducted a narrative synthesis of the available literature, reviewing impactful peer-reviewed articles produced by Brazilian scientists in the field of TB science, alongside official documents from the Brazilian Ministry of Health. This was complemented by a bibliometric analysis of the output of TB-related PhD theses (2016-2024) and PubMed-indexed publications (2001-2024) from Brazilian institutions. Finally, we discuss the systemic barriers affecting early career researchers and outline strategies for revitalizing interest and sustaining scientific progress. These include targeted TB research funds through public-private partnerships, structured mentorship programs, and competitive early career fellowships. Such interventions are essential for reversing the current decline in TB research engagement and ensuring that Brazil continues to contribute to global TB elimination efforts while preserving its scientific legacy.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e01332025
Open AccessTuberculosis and the Research Workforce Renewal Crisis in Brazil: How Can We Prevent a Future Without New Researchers?
Tuberculosis (TB) is among the oldest and deadliest infectious diseases, particularly when associated with human immunodeficiency virus (HIV) and antimicrobial resistance. Despite the progress in prevention, diagnosis, and treatment, global elimination remains elusive and is driven largely by socioeconomic inequalities and systemic challenges. Although scientific research is a cornerstone of the WHO End TB Strategy, it has been chronically underfunded and undervalued in Brazil’s health agenda. One critical consequence is the weakening of pipelines for future TB research. Funding shortages, lack of incentives, and the shifting attention toward s other emerging diseases have made it increasingly difficult to recruit and retain scientists in the field of TB. This opinion paper aimed to explore the historical role of Brazilian science in advancing TB control while addressing the emerging crisis of renewing the country’s TB scientific workforce. We conducted a narrative synthesis of the available literature, reviewing impactful peer-reviewed articles produced by Brazilian scientists in the field of TB science, alongside official documents from the Brazilian Ministry of Health. This was complemented by a bibliometric analysis of the output of TB-related PhD theses (2016-2024) and PubMed-indexed publications (2001-2024) from Brazilian institutions. Finally, we discuss the systemic barriers affecting early career researchers and outline strategies for revitalizing interest and sustaining scientific progress. These include targeted TB research funds through public-private partnerships, structured mentorship programs, and competitive early career fellowships. Such interventions are essential for reversing the current decline in TB research engagement and ensuring that Brazil continues to contribute to global TB elimination efforts while preserving its scientific legacy.
- Open Access
- 11 December 2024
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 41, 100963
Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis
- 11 December 2024
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 41, 100963
Open AccessImpact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis
- Open Access
- 10 October 2024
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 39, 100905
Nationwide economic analysis of pulmonary tuberculosis in the Brazilian healthcare system over seven years (2015–2022): a population-based study
- 10 October 2024
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 39, 100905
Open AccessNationwide economic analysis of pulmonary tuberculosis in the Brazilian healthcare system over seven years (2015–2022): a population-based study